{
  "data": {
    "asOf": "2026-10-30T22:26:37.328Z",
    "dedupMethod": "exact cross-registry identifier matching; probabilistic = review only",
    "byRegistry": {
      "clinicaltrials_gov": 1
    },
    "canonicalTrial": {
      "canonicalId": "NCT03762850",
      "title": "A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy",
      "scientificTitle": "A Randomized, Multicenter, Double-blind, Parallel-group, Active-control Study of the Efficacy and Safety of Sparsentan for the Treatment of Immunoglobulin A Nephropathy",
      "status": "completed",
      "studyType": "interventional",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Immunoglobulin A Nephropathy"
      ],
      "interventions": [
        {
          "name": "sparsentan",
          "type": "DRUG",
          "description": "Target dose of 400 mg daily"
        },
        {
          "name": "irbesartan",
          "type": "DRUG",
          "description": "Target dose of 300 mg daily"
        },
        {
          "name": "Dapagliflozin",
          "type": "DRUG",
          "description": "Target dose of 10 mg daily"
        }
      ],
      "sponsor": {
        "name": "Travere Therapeutics, Inc.",
        "type": "INDUSTRY"
      },
      "locations": [
        {
          "city": "Birmingham",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Homewood",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Glendale",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Montebello",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Northridge",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "San Diego",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "San Diego",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Stanford",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Denver",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Coral Springs",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Hollywood",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Miami",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Miami",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Winter Park",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Lawrenceville",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Nampa",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Hinsdale",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Muncie",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Kansas City",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Louisville",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Boston",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Springfield",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Worcester",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Minneapolis",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Reno",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Fresh Meadows",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "New York",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Cleveland",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Columbus",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Philadelphia",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Columbia",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "El Paso",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Fort Worth",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Houston",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Lewisville",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "San Antonio",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Salt Lake City",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Salt Lake City",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Tacoma",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Marshfield",
          "country": "United States",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Concord",
          "country": "Australia",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Gosford",
          "country": "Australia",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Kingswood",
          "country": "Australia",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "New Lambton Heights",
          "country": "Australia",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Randwick",
          "country": "Australia",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "St Leonards",
          "country": "Australia",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Birtinya",
          "country": "Australia",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Adelaide",
          "country": "Australia",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Reservoir",
          "country": "Australia",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Nedlands",
          "country": "Australia",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Bonheiden",
          "country": "Belgium",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Bruges",
          "country": "Belgium",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Ghent",
          "country": "Belgium",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Kortrijk",
          "country": "Belgium",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Liège",
          "country": "Belgium",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Roeselare",
          "country": "Belgium",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Osijek",
          "country": "Croatia",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Zagreb",
          "country": "Croatia",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Prague",
          "country": "Czechia",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Prague",
          "country": "Czechia",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Tallinn",
          "country": "Estonia",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Tallinn",
          "country": "Estonia",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Tartu",
          "country": "Estonia",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Marseille",
          "country": "France",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Montpellier",
          "country": "France",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Grenoble",
          "country": "France",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Paris",
          "country": "France",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Saint-Priest-en-Jarez",
          "country": "France",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Clermont-Ferrand",
          "country": "France",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Créteil",
          "country": "France",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Paris",
          "country": "France",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Villingen-Schwenningen",
          "country": "Germany",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Hanover",
          "country": "Germany",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Aachen",
          "country": "Germany",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Düsseldorf",
          "country": "Germany",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Kaiserslautern",
          "country": "Germany",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Trier",
          "country": "Germany",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Kiel",
          "country": "Germany",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Kiel",
          "country": "Germany",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Jena",
          "country": "Germany",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Berlin",
          "country": "Germany",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Kwun Tong",
          "country": "Hong Kong",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Lai Chi Kok",
          "country": "Hong Kong",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Shatin",
          "country": "Hong Kong",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Tsuen Wan",
          "country": "Hong Kong",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Hong Kong",
          "country": "Hong Kong",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Ranica",
          "country": "Italy",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Milan",
          "country": "Italy",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Bari",
          "country": "Italy",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Catania",
          "country": "Italy",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Catanzaro",
          "country": "Italy",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Lecco",
          "country": "Italy",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Modena",
          "country": "Italy",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Pavia",
          "country": "Italy",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Roma",
          "country": "Italy",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Torino",
          "country": "Italy",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Kaunas",
          "country": "Lithuania",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Vilnius",
          "country": "Lithuania",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Grafton",
          "country": "New Zealand",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Hamilton",
          "country": "New Zealand",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Hastings",
          "country": "New Zealand",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "New Plymouth",
          "country": "New Zealand",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Krakow",
          "country": "Poland",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Lodz",
          "country": "Poland",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Olsztyn",
          "country": "Poland",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Olsztyn",
          "country": "Poland",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Warsaw",
          "country": "Poland",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Wroclaw",
          "country": "Poland",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Coimbra",
          "country": "Portugal",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Lisbon",
          "country": "Portugal",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Lisbon",
          "country": "Portugal",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Loures",
          "country": "Portugal",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Setúbal",
          "country": "Portugal",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Vila Nova de Gaia",
          "country": "Portugal",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Seongnam-si",
          "country": "South Korea",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Anyang-si",
          "country": "South Korea",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Busan",
          "country": "South Korea",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Incheon",
          "country": "South Korea",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Seoul",
          "country": "South Korea",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Seoul",
          "country": "South Korea",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Seoul",
          "country": "South Korea",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Seoul",
          "country": "South Korea",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Seoul",
          "country": "South Korea",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Seoul",
          "country": "South Korea",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Palma de Mallorca",
          "country": "Spain",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Sagunto",
          "country": "Spain",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Barcelona",
          "country": "Spain",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Barcelona",
          "country": "Spain",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Barcelona",
          "country": "Spain",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Barcelona",
          "country": "Spain",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Madrid",
          "country": "Spain",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Madrid",
          "country": "Spain",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Madrid",
          "country": "Spain",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Seville",
          "country": "Spain",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Valencia",
          "country": "Spain",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Valencia",
          "country": "Spain",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Zaragoza",
          "country": "Spain",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Hualien City",
          "country": "Taiwan",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Kaohsiung City",
          "country": "Taiwan",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Kaohsiung City",
          "country": "Taiwan",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "New Taipei City",
          "country": "Taiwan",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Taichung",
          "country": "Taiwan",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Reading",
          "country": "United Kingdom",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Cambridge",
          "country": "United Kingdom",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Middlesbrough",
          "country": "United Kingdom",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Derby",
          "country": "United Kingdom",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Brighton",
          "country": "United Kingdom",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "London",
          "country": "United Kingdom",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "London",
          "country": "United Kingdom",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Manchester",
          "country": "United Kingdom",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Salford",
          "country": "United Kingdom",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Preston",
          "country": "United Kingdom",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Leicester",
          "country": "United Kingdom",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Edinburgh",
          "country": "United Kingdom",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Stoke-on-Trent",
          "country": "United Kingdom",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Glasgow",
          "country": "United Kingdom",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Carshalton",
          "country": "United Kingdom",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Cardiff",
          "country": "United Kingdom",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Birmingham",
          "country": "United Kingdom",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "Liverpool",
          "country": "United Kingdom",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "London",
          "country": "United Kingdom",
          "facility": "Travere Investigational Site"
        },
        {
          "city": "London",
          "country": "United Kingdom",
          "facility": "Travere Investigational Site"
        }
      ],
      "outcomes": {
        "other": [],
        "primary": [
          "Percent Change From Baseline in the Urine Protein/Creatinine (UP/C) at Week 36"
        ],
        "secondary": [
          "Total Slope of Estimated Glomerular Filtration Rate (eGFR) Over a 110-week Period",
          "Annualized Slope of eGFR Following the Initial Acute Effect of Randomized Treatment (Chronic Slope)"
        ]
      },
      "eligibility": {
        "sex": "ALL",
        "criteria": "Key Inclusion Criteria for the Double-Blind Period:\n\n* Age 18 years or older at screening\n* Biopsy-proven primary IgAN\n* Proteinuria of ≥1 g/day at screening\n* eGFR ≥30 mL/min/1.73 m2 at screening\n* Currently on stable dose of ACEI and/or ARB therapy, for at least 12 weeks prior to screening (maximum tolerated dose and at least one-half of the maximum labeled dose)\n* Systolic BP ≤150 mmHg and diastolic BP ≤100 mmHg at screening\n* Willing to undergo change in ACEI and/or ARB and anti-hypertensive medications\n* Agree to contraception\n\nKey Exclusion Criteria for the Double-Blind Period:\n\n* IgAN secondary to another condition\n* Presence of cellular glomerular crescents in \\>25% of glomeruli on renal biopsy (if biopsy available within 6 months of screening)\n* Chronic kidney disease (CKD) in addition to IgAN\n* History of organ transplantation, with exception of corneal transplants\n* Require any prohibited medications\n* Treatment of systemic immunosuppressive medications (including corticosteroids) for \\>2 weeks within 3 months of screening\n* History of heart failure or previous hospitalization for heart failure or unexplained dyspnea, orthopnea, paroxysmal nocturnal dyspnea, ascites, and/or peripheral edema\n* Clinically significant cerebrovascular disease or coronary artery disease within 6 months of screening\n* Jaundice, hepatitis, or known hepatobiliary disease or elevations of transaminases (ALT/AST) \\>2 times upper limit of normal at screening\n* History of malignancy other than adequately treated basal cell or squamous cell skin cancer or cervical carcinoma within the past 2 years\n* Hematocrit value \\<27% (0.27 V/V) or hemoglobin value \\<9 g/dL (90 g/L) at Screening\n* Potassium \\>5.5 mEq/L (5.5 mmol/L) at Screening\n* History of alcohol of illicit drug use disorder\n* History of serious side effect or allergic response to any angiotensin II antagonist or endothelin receptor antagonist, including sparsentan or irbesartan, or has a hypersensitivity to any of the excipients in the study medications\n* For female: Pregnancy, or planning to become pregnant during the course of the study, or breastfeeding\n* Participation in a study of another investigational product within 28 days of screening\n\nKey Inclusion Criteria for the Open-Label Extension Period based on assessments at the Week 110 visit:\n\n* Completed participation in the double-blind period, including the Week 114 visit\n* Did not permanently discontinue study medication during the double-blind period\n* Agree to contraception\n\nKey Exclusion Criteria for the Open-Label Extension Period based on assessments at the Week 110 and Week 114 visits:\n\n* Progression to end-stage renal disease (ESRD) requiring renal replacement therapy (RRT)\n* Development of any criteria for discontinuation of study medication or discontinuation from the study, between Week 110 and Week 114\n* Patient was unable to initiate, or developed contraindications to, treatment with RAAS inhibitors between Week 110 and Week 114\n* eGFR ≤20 mL/min/1.73 m2 at Week 110\n* Female patient is pregnant or breastfeeding\n\nKey Inclusion Criteria for the OLE Sparsentan + SGLT2 Inhibitor Sub study:\n\n* Participating in the open-label extension and is willing and able to provide signed informed consent for participation in the open-label extension period Sub study\n* A urine protein excretion value of ≥0.3 g/day.\n* An eGFR of ≥25 mL/min/1.73m2\n* On a stable dose of sparsentan for ≥8 weeks in the open-label extension period that is the maximum tolerated dose.\n\nKey Exclusion Criteria for the OLE Sparsentan + SGLT2 Inhibitor Sub study:\n\n* Progressed to ESRD requiring RRT\n* Initiated or changed dose of a systemic immunosuppressive medication (including systemic steroids) within 12 weeks\n* Taking an SGLT2 inhibitor within 12 weeks",
        "minimumAge": "18 Years",
        "healthyVolunteers": false
      },
      "enrollment": {
        "type": "ACTUAL",
        "count": 406
      },
      "startDate": "2018-12-11",
      "completionDate": "2026-08-19",
      "lastUpdated": "2026-10-14T00:00:00.000Z",
      "firstPosted": "2018-12-04T00:00:00.000Z",
      "resultsAvailable": true,
      "sourceRegistries": [
        "clinicaltrials_gov"
      ],
      "sourceUrls": [
        "https://clinicaltrials.gov/study/NCT03762850"
      ]
    },
    "identifiers": [
      {
        "idType": "nct",
        "idValue": "NCT03762850",
        "declaredBy": "clinicaltrials_gov"
      },
      {
        "idType": "euct",
        "idValue": "2023-505495-30-00",
        "declaredBy": "clinicaltrials_gov"
      },
      {
        "idType": "eudract",
        "idValue": "2017-004605-41",
        "declaredBy": "clinicaltrials_gov"
      }
    ],
    "sourceRecords": [
      {
        "registry": "clinicaltrials_gov",
        "registryName": "ClinicalTrials.gov",
        "license": "public-domain",
        "sourceId": "NCT03762850",
        "sourceUrl": "https://clinicaltrials.gov/study/NCT03762850",
        "sourceStatus": "COMPLETED",
        "retrievedAt": "2026-10-28T04:33:03.748Z",
        "payloadSha256": "32758495a05a755cfd3b2f903061efc8d5b317a5cf99f897a72907e379976dd3",
        "piiRedacted": true
      }
    ],
    "citation": {
      "canonicalId": "NCT03762850",
      "sources": [
        {
          "registry": "clinicaltrials_gov",
          "registryName": "ClinicalTrials.gov",
          "license": "public-domain",
          "sourceId": "NCT03762850",
          "verifyAt": "https://clinicaltrials.gov/study/NCT03762850",
          "retrievedAt": "2026-10-28T04:33:03.748Z",
          "payloadSha256": "32758495a05a755cfd3b2f903061efc8d5b317a5cf99f897a72907e379976dd3",
          "text": "ClinicalTrials.gov, record NCT03762850 (https://clinicaltrials.gov/study/NCT03762850), retrieved 2026-10-28, licence: public-domain."
        }
      ],
      "crossRegistry": false,
      "dedupMethod": "exact cross-registry identifier matching; probabilistic = review only",
      "text": "Trial NCT03762850, registered in ClinicalTrials.gov, retrieved 2026-10-28. Verify at the source URLs listed; each retrieval is checksummed.",
      "note": "Only one registry is known to hold this trial. Absence from the others is not evidence it was not registered there."
    },
    "provenanceNote": "Personal contact fields (names, emails, phone numbers, addresses) are stripped from every stored payload. No participant-level data is collected or served."
  },
  "_meta": {
    "api": "The Last Economy Wire: World Trials API",
    "version": "1.0",
    "schemaVersion": "1",
    "correlationId": "req_qamrScXRgUtf",
    "generatedAt": "2026-10-30T22:26:37.328Z",
    "documentation": "https://negativeresistance.com/embed",
    "license": "Free for any use. Attribution appreciated.",
    "degraded": false,
    "provenance": {
      "sources": [
        "clinicaltrials_gov"
      ],
      "attribution": {
        "clinicaltrials_gov": "ClinicalTrials.gov: licence: public-domain, https://clinicaltrials.gov/data-api/api-docs"
      },
      "dedupMethod": "exact cross-registry identifier matching; probabilistic = review only",
      "limitations": [],
      "provenanceEndpoint": "/api/v1/sources"
    },
    "freshness": {
      "newestEvidenceAt": null,
      "lastSyncedAt": {
        "clinicaltrials_gov": "2026-10-28T04:33:30.663Z"
      },
      "degradedSources": [],
      "worldwide": false,
      "maxAgeHours": 65.9,
      "fromCache": false
    },
    "links": {
      "discovery": "https://negativeresistance.com/api/v1",
      "openapi": "https://negativeresistance.com/api/v1/openapi.json",
      "mcp": "https://negativeresistance.com/api/v1/mcp",
      "agentCard": "https://negativeresistance.com/.well-known/agent.json",
      "aiPlugin": "https://negativeresistance.com/.well-known/ai-plugin.json",
      "sdk": "https://negativeresistance.com/api/v1/sdk",
      "status": "https://negativeresistance.com/api/v1/status",
      "provenance": "https://negativeresistance.com/api/v1/sources",
      "contract": "https://negativeresistance.com/api/v1/contract",
      "curriculum": "https://negativeresistance.com/api/v1/curriculum",
      "graph": "https://negativeresistance.com/api/v1/graph",
      "openQuestions": "https://negativeresistance.com/api/v1/open-questions",
      "scoreboard": "https://negativeresistance.com/api/v1/scoreboard",
      "findings": "https://negativeresistance.com/api/v1/findings",
      "claims": "https://negativeresistance.com/api/v1/claims",
      "threads": "https://negativeresistance.com/api/v1/threads",
      "assignment": "https://negativeresistance.com/api/v1/assignment",
      "changes": "https://negativeresistance.com/api/v1/changes",
      "hello": "https://negativeresistance.com/api/v1/hello",
      "errors": "https://negativeresistance.com/api/v1/errors",
      "webhooks": "https://negativeresistance.com/api/v1/webhooks",
      "a2a": "https://negativeresistance.com/api/v1/a2a",
      "deadEnds": "https://negativeresistance.com/api/v1/dead-ends",
      "decompositions": "https://negativeresistance.com/api/v1/decompositions",
      "rungs": "https://negativeresistance.com/api/v1/rungs",
      "methods": "https://negativeresistance.com/api/v1/methods",
      "reality": "https://negativeresistance.com/api/v1/reality",
      "council": "https://negativeresistance.com/api/v1/council",
      "calibration": "https://negativeresistance.com/api/v1/calibration",
      "freshness": "https://negativeresistance.com/api/v1/freshness",
      "mission": "https://negativeresistance.com/api/v1/mission",
      "twin": "https://negativeresistance.com/api/v1/twin",
      "twinExperiment": "https://negativeresistance.com/api/v1/twin/experiment",
      "betaCell": "https://negativeresistance.com/api/v1/twin/beta-cell",
      "patientModel": "https://negativeresistance.com/api/v1/twin/patient-model",
      "agentCardCanonical": "https://negativeresistance.com/.well-known/agent-card.json",
      "collaborate": "https://negativeresistance.com/collaborate",
      "manifesto": "https://negativeresistance.com/about",
      "documentation": "https://negativeresistance.com/embed",
      "connect": "https://negativeresistance.com/connect",
      "llmsTxt": "https://negativeresistance.com/llms.txt",
      "llmsFullTxt": "https://negativeresistance.com/llms-full.txt"
    },
    "disclaimer": "Research data from public registries and literature; not medical advice."
  }
}